•
Sep 30, 2024

Ovid Therapeutics Q4 2024 Earnings Report

Total Revenue
$173K
Previous year: $142K
+22.2%
EPS
-$0.13
Previous year: -$0.22
-40.9%
Gross Profit
$4K
Cash and Equivalents
$62.7M
Previous year: $106M
-40.7%
Free Cash Flow
-$15M
Previous year: -$11.9M
+25.8%
Total Assets
$103M
Previous year: $144M
-28.7%

Ovid Therapeutics

Ovid Therapeutics